171 related articles for article (PubMed ID: 33448146)
1. Cascade Catalytic Nanoplatform Based on "Butterfly Effect" for Enhanced Immunotherapy.
Shao Y; Wang Z; Hao Y; Zhang X; Wang N; Chen K; Chang J; Feng Q; Zhang Z
Adv Healthc Mater; 2021 Apr; 10(8):e2002171. PubMed ID: 33448146
[TBL] [Abstract][Full Text] [Related]
2. Two-pronged microenvironmental modulation of metal-oxidase cascade catalysis and metabolic intervention for synergistic tumor immunotherapy.
Song Q; Gao H; Sun S; Li Y; Wu X; Yang J; Wang B; Zhang Y; Wang L
Acta Biomater; 2024 Jan; 173():378-388. PubMed ID: 37925121
[TBL] [Abstract][Full Text] [Related]
3. Novel Tumor-Microenvironment-Based Sequential Catalytic Therapy by Fe(II)-Engineered Polydopamine Nanoparticles.
Zhu Y; Xin N; Qiao Z; Chen S; Zeng L; Zhang Y; Wei D; Sun J; Fan H
ACS Appl Mater Interfaces; 2019 Nov; 11(46):43018-43030. PubMed ID: 31660723
[TBL] [Abstract][Full Text] [Related]
4. Rapid Decomposition and Catalytic Cascade Nanoplatforms Based on Enzymes and Mn-Etched Dendritic Mesoporous Silicon for MRI-Guided Synergistic Therapy.
Liu B; Wang Z; Li T; Sun Q; Dong S; Zhong C; Yang D; He F; Gai S; Yang P
ACS Appl Mater Interfaces; 2020 Oct; 12(41):45772-45788. PubMed ID: 32969221
[TBL] [Abstract][Full Text] [Related]
5. Catalytically Active Metal-Organic Frameworks Elicit Robust Immune Response to Combination Chemodynamic and Checkpoint Blockade Immunotherapy.
Wang X; Luo J; Wang J; Cao J; Hong Y; Wen Q; Zeng Y; Shi Z; Ma G; Zhang T; Huang P
ACS Appl Mater Interfaces; 2023 Feb; 15(5):6442-6455. PubMed ID: 36700645
[TBL] [Abstract][Full Text] [Related]
6. GSH-Responsive Organosilica Hybrid Nanosystem as a Cascade Promoter for Enhanced Starvation and Chemodynamic Therapy.
Wu H; Li X; Liu S; Wang Q; Cao Y; Hao JN; Li Y
Adv Healthc Mater; 2023 Jan; 12(2):e2201262. PubMed ID: 36213949
[TBL] [Abstract][Full Text] [Related]
7. Biomimetic Nanoarchitectonics of Hollow Mesoporous Copper Oxide-Based Nanozymes with Cascade Catalytic Reaction for Near Infrared-II Reinforced Photothermal-Catalytic Therapy.
Wang J; Ye J; Lv W; Liu S; Zhang Z; Xu J; Xu M; Zhao C; Yang P; Fu Y
ACS Appl Mater Interfaces; 2022 Sep; 14(36):40645-40658. PubMed ID: 36040363
[TBL] [Abstract][Full Text] [Related]
8. Combining Cobalt Ferrite Nanozymes with a Natural Enzyme to Reshape the Tumor Microenvironment for Boosted Cascade Enzyme-Like Activities.
Chang J; Qin X; Li S; He F; Gai S; Ding H; Yang P
ACS Appl Mater Interfaces; 2022 Oct; 14(40):45217-45228. PubMed ID: 36190449
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment responsive polypeptide-based supramolecular nanoprodrugs for combination therapy.
Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Dong CM; Yao Y
Acta Biomater; 2022 Jul; 146():396-405. PubMed ID: 35470074
[TBL] [Abstract][Full Text] [Related]
10. Triggering Sequential Catalytic Fenton Reaction on 2D MXenes for Hyperthermia-Augmented Synergistic Nanocatalytic Cancer Therapy.
Liang R; Li Y; Huo M; Lin H; Chen Y
ACS Appl Mater Interfaces; 2019 Nov; 11(46):42917-42931. PubMed ID: 31635454
[TBL] [Abstract][Full Text] [Related]
11. Augmenting Immunotherapy via Bioinspired MOF-Based ROS Homeostasis Disruptor with Nanozyme-Cascade Reaction.
Wang R; Qiu M; Zhang L; Sui M; Xiao L; Yu Q; Ye C; Chen S; Zhou X
Adv Mater; 2023 Dec; 35(49):e2306748. PubMed ID: 37689996
[TBL] [Abstract][Full Text] [Related]
12. Tumor Microenvironment-Responsive and Catalytic Cascade-Enhanced Nanocomposite for Tumor Thermal Ablation Synergizing with Chemodynamic and Chemotherapy.
Zhang Y; Cao Y; Gao T; Kuang Y; An Z; Mao Z; He Y; Yan J; Lu Z; Pei R
ACS Appl Bio Mater; 2020 Jun; 3(6):3880-3893. PubMed ID: 35025258
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Microenvironment-Activated Reactive Oxygen Species Amplifier for Enzymatic Cascade Cancer Starvation/Chemodynamic /Immunotherapy.
Wang M; Chang M; Li C; Chen Q; Hou Z; Xing B; Lin J
Adv Mater; 2022 Jan; 34(4):e2106010. PubMed ID: 34699627
[TBL] [Abstract][Full Text] [Related]
14. Tumor Microenvironment-Activated Nanocomposite for Self-Amplifying Chemodynamic/Starvation Therapy Enhanced IDO-Blockade Tumor Immunotherapy.
Bian Y; Liu B; Ding B; Wang M; Yuan M; Ma P; Lin J
Adv Sci (Weinh); 2023 Dec; 10(34):e2303580. PubMed ID: 37807763
[TBL] [Abstract][Full Text] [Related]
15. A Multifunctional Cascade Bioreactor Based on Hollow-Structured Cu
Chang M; Wang M; Wang M; Shu M; Ding B; Li C; Pang M; Cui S; Hou Z; Lin J
Adv Mater; 2019 Dec; 31(51):e1905271. PubMed ID: 31680346
[TBL] [Abstract][Full Text] [Related]
16. MOF-derived cobalt-iron containing nanocomposite with cascade-catalytic activities for multimodal synergistic tumor therapy.
Jiang Y; Lu H; Lei L; Yuan X; Scherman D; Liu Y
Colloids Surf B Biointerfaces; 2024 May; 240():113981. PubMed ID: 38815310
[TBL] [Abstract][Full Text] [Related]
17. Degradable Fe
Wang Y; Li X; Fang Y; Wang J; Yan D; Chang B
RSC Adv; 2023 Mar; 13(12):7952-7962. PubMed ID: 36909758
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen Sulfide Gas Amplified ROS Cascade: FeS@GOx Hybrid Nanozyme Designed for Boosting Tumor Chemodynamic Immunotherapy.
Sun W; Zhu C; Song J; Ji SC; Jiang BP; Liang H; Shen XC
Adv Healthc Mater; 2023 Sep; 12(23):e2300385. PubMed ID: 37040018
[TBL] [Abstract][Full Text] [Related]
19. Reinforcing the Induction of Immunogenic Cell Death Via Artificial Engineered Cascade Bioreactor-Enhanced Chemo-Immunotherapy for Optimizing Cancer Immunotherapy.
Sun K; Hu J; Meng X; Lei Y; Zhang X; Lu Z; Zhang L; Wang Z
Small; 2021 Sep; 17(37):e2101897. PubMed ID: 34363310
[TBL] [Abstract][Full Text] [Related]
20. Cascade catalytic nanoplatform for enhanced starvation and sonodynamic therapy.
Zhang Y; Wang H; Jia X; Du S; Yin Y; Zhang X
J Drug Target; 2020 Feb; 28(2):195-203. PubMed ID: 31282750
[No Abstract] [Full Text] [Related]
[Next] [New Search]
